ABELACIMAB
UNII KX1N4TV7UY

Substance Identification & Data

This profile provides standardized clinical and technical data for Abelacimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KX1N4TV7UY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2098724-83-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
KX1N4TV7UY
CAS Registry Number
2098724-83-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ABELACIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C169755
National Cancer Institute reference terminology for clinical and research data.
INN ID
10881
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Abelacimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ABELACIMAB

Common Names & Synonyms

ABELACIMAB [INN]
ABELACIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN BLOOD-COAGULATION FACTOR XI) (HUMAN MONOCLONAL CLONE NVS250519 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL NVS250519 .LAMBDA.-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus